Article
Chromatin modifying gene mutations in follicular lymphoma.
Blood - 8 Feb 2018
Green Michael R
Abstract excerpt
Follicular lymphoma (FL) is an indolent malignancy of germinal center B cells. Although the overall survival of FL patients has recently improved with the introduction of novel therapies, there is significant heterogeneity in patient outcome and a need for rationally designed therapeutic strategies that target disease biology. Next-generation sequencing studies have identified chromatin modifying gene (CMG)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
